InVitro International, Inc. (IVRO)
OTCMKTS
· Delayed Price · Currency is USD
0.0822
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST
InVitro International Revenue
In the fiscal year ending September 30, 2024, InVitro International had annual revenue of $811.29K with 2.35% growth. InVitro International had revenue of $213.39K in the quarter ending September 30, 2008, with 84.11% growth.
Revenue
811.29K
Revenue Growth
-26.57%
P/S Ratio
2.26
Revenue / Employee
50.71K
Employees
16
Market Cap
1.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 811.29K | 18.66K | 2.35% |
| Sep 30, 2023 | 792.63K | -60.88K | -7.13% |
| Sep 30, 2022 | 853.51K | -149.89K | -14.94% |
| Sep 30, 2021 | 1.00M | -101.41K | -9.18% |
| Sep 30, 2020 | 1.10M | 52.08K | 4.95% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Centogene | 53.65M |
| IDenta | 1.24M |
| ProPhase Labs | 5.06M |
| NovelStem International | 3.00K |
| Psychemedics | 19.69M |
| Aspira Women's Health | 9.34M |
| Longduoduo Company | 2.72M |
| Bioqual | 46.54M |